GLP-1 Receptor Agonist Market Report 2026 Global Outlook By Drug Class (Exenatide, Liraglutide, Dulaglutide, Lixisenatide, Other Drugs), By Route Of Administration (Parenteral, Oral), By End Users (Hospitals, Surgical Clinics, Other Users) Market Size, Trends, Strategies, and Forecast to 2035 GLP-1 Receptor Agonist Market Overview GLP-1 Receptor Agonist market size has reached to $14.09 billion in 2025 Expected to grow to $18.32 billion in 2030 at a compound annual growth rate (CAGR) of 5.4% Growth Driver: Surging Diabetes Cases Fuel Growth In Glp-1 Receptor Agonist Market Market Trend: Sustained-Release Glp-1 Receptor Agonists Are Gaining Popularity North America was the largest region in 2025 and Asia-Pacific is the fastest growing region
Slowing Digestion One of semaglutides most powerful effects is its ability to slow gastric emptying, which means food stays in your stomach longer, helping you feel fuller and reducing the urge to overeat
Similar content being viewed by others Introduction Diabetes mellitus represents a significant healthcare challenge in the US, with 24.7 million people with a diagnosis, leading to direct healthcare expenditure of US dollars (USD) 237 billion and USD 90 billion in lost productivity in 2017 [1]
GLOW targets dermal structure
I can go and have dinner with friends and not have to eat every piece of bread on the table, and then not go have ice cream when Ive done with dinner. People dont understand that being fat is not a choice, he added
Prevalence and correlates of food addiction: systematic review of studies with the YFAS 2.0